SkinBioTherapeutics plc (LON:SBTX – Get Free Report) traded down 6.8% on Wednesday . The stock traded as low as GBX 12.15 ($0.16) and last traded at GBX 12.70 ($0.16). 883,025 shares changed hands during trading, a decline of 5% from the average session volume of 925,292 shares. The stock had previously closed at GBX 13.63 ($0.18).
SkinBioTherapeutics Trading Down 8.3 %
The company has a fifty day simple moving average of GBX 12.10 and a two-hundred day simple moving average of GBX 10.77. The company has a debt-to-equity ratio of 2.66, a current ratio of 6.57 and a quick ratio of 10.01. The company has a market capitalization of £28.26 million, a P/E ratio of -681.25 and a beta of 2.01.
SkinBioTherapeutics Company Profile
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Featured Articles
- Five stocks we like better than SkinBioTherapeutics
- Manufacturing Stocks Investing
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Find and Profitably Trade Stocks at 52-Week Lows
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Buy P&G Now, Before It Sets A New All-Time High
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
